Targeting of GD2-positive tumor cells by
β
Claudia Rossig; Catherine M. Bollard; Jed G. Nuchtern; Durriya A. Merchant; Malc
π
Article
π
2001
π
John Wiley and Sons
π
French
β 241 KB
π 1 views
Genetic engineering of human T lymphocytes to express tumor antigen-specific chimeric immune receptors is an attractive means for providing large numbers of effector cells for adoptive immunotherapy while bypassing major mechanisms of tumor escape from immune recognition. We have applied this strate